Jan 18, 2013, 07:00 AM by Michael Croft

New York Times | Ayasdi, a new data analysis start-up based in Palo Alto, is based on a new fundamental technique of mathmatics analysis. The technique analyzes the shape of complex data.

Jan 17, 2013, 12:00 PM by Michael Croft

Jan 17, 2013, 10:00 AM by Michael Croft

HHMI Bulletin | Sydney Brenner spends part of his time at Janelia Farm as a senior reserach fellow. He talks with the HHMI Bulletin about what is working at Janelia Farm and what challenges the labs face.

Jan 16, 2013, 10:00 AM by Michael Croft

Bio-IT World | AstraZeneca is expanding its biotechnology operations in Russia, through the establishment of the country’s first biobank and a clinical research center in St. Petersburg. 

Jan 16, 2013, 07:00 AM by Michael Croft

In the Pipeline | It seems to be a season of shake ups in Big Pharma, and Derek Lowe is trading theories. Right now, the predominant ones include changes at Pfizer and AstraZeneca.

Jan 15, 2013, 05:55 AM by Michael Croft

Bio-IT World | Today's launch of Silicon Valley Biosystems (SV Bio), an in silico diagnostics company established by Navigenics co-founder Dietrich Stephan, is marked by the resolution of a lengthy diagnostic odyssey in which exome sequencing revealed the underlying mutated gene responsible for two siblings’ neurological disorder.

Jan 14, 2013, 11:00 AM by Michael Croft

Jan 14, 2013, 10:00 AM by Michael Croft

ReadWriteWeb | HANA, SAP's in-memory database, is now ready to run SAP's enterprise resource planning applications. HANA is capable of both data warehousing and transactions--like forecasting--making both processes much faster.

Jan 14, 2013, 08:00 AM by Michael Croft

Bio-IT World | GUEST COMMENTARY | Two years ago, venture capitalist Hermann Hauser boldly predicted the fall of Intel. The tech giant would be crushed, he said, by the mighty ARM (Advanced RISC Machines) Holdings. Such posturing is not uncommon in the world of technology, but the difference in this case was that Hauser was pointing to the business models of the two companies, not the technology per se.

Jan 14, 2013, 07:00 AM by Michael Croft

Edge | Edge has posted its annual question and there are some great responses: essays from Steve Pinker, Craig Venter, Brian Eno, Tim O’Reilly, Simon Baron-Cohen, Terry Sejnowski, Eric Topol, Nicholas Carr, Esther Dyson, Juan Enriquez, and a cast of 130 other scientific leaders.

Jan 11, 2013, 11:00 AM by Michael Croft

NGS Leaders | Justin Zook and Marc Salit from the National Institute of Standards and Technology report on the NIST workshop Genome in a Bottle, to develop reference materials, reference methods, and reference data to assess confidence in human whole genome variant calls.

Jan 11, 2013, 08:00 AM by Michael Croft

Jan 10, 2013, 14:00 PM by Michael Croft

Nature | Researchers at the University of Manchester have built a robotic ribosome, or at least a nanomachine  that can mimic some of a ribosome's activity.

Jan 10, 2013, 13:00 PM by Michael Croft

eWeek | A Gartner study suggests that the rising costs of big data storage is going to lead some businesses trade, barter, or sell their data for funds by 2016.

Jan 10, 2013, 09:00 AM by Michael Croft

InfoWorld | InfoWorld's Technology of the Year awards recognizes the best tech solutions from 2012. Among them, hardware, software, cloud solutions, and more.

Jan 9, 2013, 10:00 AM by Michael Croft

Bio-IT World | SINGAPORE—Bayer HealthCare has launched an Integrated Translational Oncology Network in Singapore to facilitate drug discovery and development specifically for cancers prevalent in Asian populations.  

Jan 8, 2013, 06:55 AM by Michael Croft

Bio-IT World | The two giants of next-generation sequencing technology, Illumina and Life Technologies, have announced rival initiatives with leading medical institutions in Boston to further the integration of their technology into the clinical genomics arena. Life is investing in Claritas Genomics with Boston Children's Hospital, while Illumina announced the founding members of the GeneInsight-Illumina Network.

Jan 7, 2013, 15:00 PM by Michael Croft

Wall Street Journal Blogs | Data scientists need to have a hybrid set of IT skills, says one big data professional. In a shift from big data (focus on the data) to data science (focus on the science), data-science-oriented disciplines like information-based medicine aim to leverage all sources of data to develop new scientific methods of inquiry.

Jan 7, 2013, 09:00 AM by Michael Croft

Pittsburgh Business Times | The University of Pittsburgh Schools of Health Services is launching a new Institute of Personalized Medicine to use genetics, genomics and related information from other disciplines to advance evidence-based medicine, practices and procedures that have been proven effective.

Jan 7, 2013, 09:00 AM by Michael Croft

Bio-IT World | The pharmaceutical industry could use a fortuneteller. According to a March 2010 issue of Nature Reviews Drug Discovery, drug companies spend on average $1.8 billion dollars to bring a new therapy to market, and that number is estimated to increase in the coming years. This staggering figure is due in part to the lack of predictive algorithms.